{"organizations": [], "uuid": "cf9a8d45c88b9483ed991af863e1ae18dcf97747", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-22nd-century-ceo-henry-sicignano-t/brief-22nd-century-ceo-henry-sicignano-to-discuss-fdas-nicotine-reduction-plan-with-institutional-investors-idUSFWN1R10QE", "country": "US", "domain_rank": 408, "title": "BRIEF-22nd Century ‍CEO Henry Sicignano To Discuss FDA's Nicotine Reduction Plan With Institutional Investors", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-19T15:29:00.000+02:00", "replies_count": 0, "uuid": "cf9a8d45c88b9483ed991af863e1ae18dcf97747"}, "author": "", "url": "https://www.reuters.com/article/brief-22nd-century-ceo-henry-sicignano-t/brief-22nd-century-ceo-henry-sicignano-to-discuss-fdas-nicotine-reduction-plan-with-institutional-investors-idUSFWN1R10QE", "ord_in_thread": 0, "title": "BRIEF-22nd Century ‍CEO Henry Sicignano To Discuss FDA's Nicotine Reduction Plan With Institutional Investors", "locations": [], "entities": {"persons": [{"name": "henry sicignano", "sentiment": "negative"}, {"name": "henry sicignano to discuss", "sentiment": "negative"}], "locations": [{"name": "new york", "sentiment": "none"}, {"name": "chicago", "sentiment": "none"}, {"name": "boston", "sentiment": "none"}], "organizations": [{"name": "fda", "sentiment": "negative"}, {"name": "century group inc", "sentiment": "none"}, {"name": "institutional investors reuters", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 19, 2018 / 1:31 PM / Updated 24 minutes ago BRIEF-22nd Century ‍CEO Henry Sicignano To Discuss FDA's Nicotine Reduction Plan With Institutional Investors Reuters Staff 1 Min Read March 19 (Reuters) - 22Nd Century Group Inc: * 22ND CENTURY - CO’S ‍CEO HENRY SICIGNANO III​ TO DISCUSS FDA’S NICOTINE REDUCTION PLAN WITH INSTITUTIONAL INVESTORS IN NEW YORK, CHICAGO AND BOSTON Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-03-19T15:29:00.000+02:00", "crawled": "2018-03-19T15:52:10.000+02:00", "highlightTitle": ""}